Distributed

No. 23-9

AstraZeneca UK Limited, et al. v. Joshua Atchley, et al.

from the United States Court of Appeals for the District of Columbia Circuit

See other cases from the District of Columbia Circuit.

Docket Entries

The Solicitor General is invited to file a brief in this case expressing the views of the United States. Justice Alito took no part in the consideration of this petition.

Reply of petitioners AstraZeneca UK Limited, et al. filed. (Distributed)

DISTRIBUTED for Conference of 9/26/2023.

Brief of respondents Joshua Atchley, et al. in opposition filed.

Brief amici curiae of Chamber of Commerce of the United States of America, et al. filed.

Motion to extend the time to file a response is granted and the time is extended to and including August 23, 2023.

Motion to extend the time to file a response from August 4, 2023 to August 23, 2023, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due August 4, 2023)

Application (22A868) granted by The Chief Justice extending the time to file until July 2, 2023.

Application (22A868) to extend the time to file a petition for a writ of certiorari from May 4, 2023 to July 3, 2023, submitted to The Chief Justice.

Parties

AstraZeneca UK Limited, et al., Petitioner, represented by Lisa Schiavo Blatt

Joshua Atchley, et al., Respondent, represented by Joshua Daniel Branson

Amici Curiae

Chamber of Commerce of the United States of America and Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Andrew John Pincus

 
Last updated: April 25, 2024